Bio-Rad Laboratories | BIO - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Agilent USD 852M 19M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio Techne USD 104.6M 6.16M 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Bruker USD 528M 46.9M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Danaher USD 2.36B 512M 2026-03
General Electric Aerospace USD 8.15B 764M 2026-03
Illumina USD 400M 49M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Merck USD 3.32B 531M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Siemens EUR 11.51B 1.82B 2025-12
Standard Biotools USD 12.41M 2.34M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Tosoh JPY 190.27B 3.82B 2025-12
Waters USD 374.94M 47.13M 2025-12